688046 GemPharmatech
- 12.13
- +0.02+0.17%
GemPharmatech News
Announcement on holding a briefing on 2024 semi-annual results and cash dividends
Yakkang Biotech: Announcement on the results of shareholding reduction results for shareholders holding 5% or more of the shares
Announcement on the results of shareholding reduction results for shareholders holding 5% or more of the shares
Announcement on the progress of the repurchase of company shares through centralized bidding transactions
Yakang Biology: Legal Opinion of Jiangsu Century Tongren Law Firm on the 2024 First Extraordinary General Meeting of Shareholders of Jiangsu Jicui Yakang Biotechnology Co., Ltd.
Yakang Biotech: Announcement of Resolutions of Yakang Biotech\'s 2024 First Extraordinary General Meeting of Shareholders
Legal Opinion of Jiangsu Century Tongren Law Firm on the 2024 First Extraordinary General Meeting of Shareholders of Jiangsu Jicui Yakang Biotechnology Co., Ltd.
Announcement of Resolutions of the 2024 First Extraordinary General Meeting of Shareholders of Yakkang Biotech
Simplified Statement of Changes in Equity
An indicative announcement on changes in the equity of shareholders holding 5% or more of the shares to reduce the shareholding ratio to 5% or less
Huatai United Securities Co., Ltd.\'s 2024 semi-annual continuous supervision and follow-up report on Jiangsu Jicui Yakang Biotechnology Co., Ltd.
Materials of the 2024 First Extraordinary General Meeting of Shareholders of Yakkang Biotech
Announcement on the progress of the repurchase of company shares through centralized bidding transactions
Notice on holding the 2024 First Extraordinary General Meeting of Shareholders
Announcement of Resolutions of the 7th Meeting of the 2nd Board of Directors
Special report on the storage and actual use of funds raised by the company for the first half year of 2024
Semi-annual Evaluation Report on the 2024 “Improve Quality, Increase Efficiency, and Focus on Rewards” Action Plan
Yakkang Biotech 2024 Semi-Annual Report
Summary of Yakkang Biotech\'s 2024 Semi-Annual Report
Announcement of Resolutions of the Sixth Meeting of the Second Board of Supervisors
Analysis
Price Target
No Data
No Data